The effects of substance P and other peptides on spinal neurons of the frog.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology; D002108:Ceruletide / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004594:Electrophysiology; D004600:Eledoisin / Q000494:pharmacology*; D005971:Glutamates / Q000494:pharmacology*; D007395:Interneurons / Q000187:drug effects; D009046:Motor Neurons / Q000187:drug effects; D009411:Nerve Endings / Q000378:metabolism; D009474:Neurons / Q000187:drug effects*; D018377:Neurotransmitter Agents / Q000378:metabolism; D010455:Peptides / Q000494:pharmacology*; D011892:Rana catesbeiana; D012018:Reflex / Q000187:drug effects; D013116:Spinal Cord / Q000166:cytology* / Q000187:drug effects; D013126:Spinal Nerve Roots / Q000187:drug effects; D013268:Stimulation, Chemical; D013373:Substance P / Q000494:pharmacology*; D009435:Synaptic Transmission / Q000187:drug effects
D005971:Glutamates; D018377:Neurotransmitter Agents; D010455:Peptides; D000804:Angiotensin II; D013373:Substance P; D004600:Eledoisin; D002108:Ceruletide; D001920:Bradykinin